Granisetron Transdermal Patch and Osimertinib: Interaction Details
- Granisetron Transdermal Patch
- SancusoSustolGranisol
- Osimertinib
- Tagrisso
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Granisetron Transdermal Patch and Osimertinib interaction:
Granisetron Transdermal Patch
- Sancuso
- Sustol
- Granisol
What Happens When You Take Granisetron Transdermal Patch With Osimertinib
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Whenever possible, do not co-administer this agent with drugs that are known to prolong the and carry a recognized risk of . If using them together cannot be avoided, monitoring should be performed at regular intervals.1
The Granisetron Transdermal Patch and Osimertinib Interaction, Explained
Both granisetron (the Sancuso patch, used to prevent nausea from chemotherapy) and osimertinib (Tagrisso, a lung cancer medicine) can affect the heart's electrical rhythm. Each one can slightly lengthen what's called the , which you can see on an . Together, the effect could add up, which may raise the chance of an irregular heart rhythm.
This concern is mostly theoretical, meaning it's based on how the drugs work rather than on many reported cases. Please don't stop either medicine on your own. Tell your pharmacist or doctor about both, and let them know if you ever feel faint, dizzy, or notice a racing or fluttering heartbeat. Your care team may check your heart tracing (ECG) from time to time to keep you safe.
Mechanism: (both agents have labeled QT effects). Neither effect is a PK interaction, so direction is increased arrhythmic risk, not altered drug exposure.
- Evidence: theoretical; no specific clinical data for this pair. Onset unspecified.
- Severity on file: major.
- Management: avoid if possible. If necessary, obtain periodic monitoring. Consider baseline , electrolytes (K, Mg, Ca), and review of other QT-prolonging drugs and risk factors (e.g., , cardiac disease, antiemetic co-therapy).
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Granisetron Transdermal Patch and Osimertinib Interact
The likely mechanism
How to Manage the Granisetron Transdermal Patch and Osimertinib Interaction
Your care team may try to avoid using these two together if there is a good alternative. If both are needed, they usually check your periodically to watch your heart rhythm.
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Give your pharmacist and doctor a full list of your medicines, including other ones that affect heart rhythm.
- Report fainting, dizziness, palpitations, or a racing or irregular heartbeat promptly.
Your care team can tailor the plan and monitoring to you.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Granisetron Transdermal Patch or Osimertinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Granisetron Transdermal Patch and Osimertinib: Common Questions
How serious is the Granisetron Transdermal Patch and Osimertinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Granisetron Transdermal Patch and Osimertinib interaction managed?
Your care team may try to avoid using these two together if there is a good alternative. If both are needed, they usually check your periodically to watch your heart rhythm. Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Give your pharmacist and doctor a full list of your medicines, including other ones that affect heart rhythm. Report fainting, dizziness, p… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Granisetron Transdermal Patch and Osimertinib Interaction
Ask in your own words about taking Granisetron Transdermal Patch and Osimertinib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per manufacturer), Wilmington, DE, 2018. DailyMed
Other Serious Interactions of Granisetron Transdermal Patch and Osimertinib
Also serious with Granisetron Transdermal Patch
- DronedaroneContraindicated
- FluconazoleContraindicated
- LevoketoconazoleContraindicated
- PhenelzineContraindicated
Also serious with Osimertinib
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.